相关实验视频

Updated: May 9, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

斯诺德67通过引导U6修饰和调节拼接景观来促进乳腺癌转移

Yvonne L Chao^1,2,3,4,5, Katherine I Zhou^1,6,7, Kwame K Forbes^7,8

¹University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

Nature communications

|May 2, 2025

概括

像Snord67这样的小核RNAs (snoRNAs) 是乳腺癌转移的关键调节者. 失去了Snord67通过改变RNA拼接来抑制淋巴结的扩散和远程瘤的生长.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

小核RNAs (snoRNAs) 在历史上被视为家政基因.
新出现的证据强调了snoRNAs在癌症发展中的多样性作用.
斯诺RNAs在癌症转移中的特定参与仍未得到充分研究.

研究的目的:

为了研究snoRNAs在乳腺癌转移中的作用.
为了识别参与淋巴结 (LN) 转移的特定snoRNAs.
阐明snoRNAs影响转移过程的分子机制.

主要方法:

利用了乳腺癌的免疫能力和正位素小鼠模型.
分析了淋巴结转移中的Snord67表达.
在乳腺癌细胞系中进行了Snord67的淘汰实验.
评估了Snord67损失对U6小核RNA甲基化和RNA拼接模式的影响.

主要成果:

发现Snord67表达在乳腺癌的淋巴结转移中被丰富.
在 ортотоп模型中,Snord67的耗尽显著减少了淋巴结转移.
失去了Snord67损害了淋巴结瘤的生长,并减少了远程转移.
斯诺德67的淘汰导致U6小核RNA上的2 -O-甲基化损失和广泛的拼接变化.

结论:

在乳腺癌中,Snord67作为淋巴结转移的关键调节剂.
Snord67促进了淋巴结中的乳腺癌生长和随后的远程传播.
由SnoRNA介导的拼接调节代表了癌症转移的潜在治疗标.

更多相关视频

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

相关概念视频

RNA Splicing

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...